NCT06132165View on ClinicalTrials.gov

Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Neurofibromatosis 1
Interventions
DRUG

Deoxycholic Acid

Injection into the cutaneous Neurofibromas lesion.

DRUG

Polidocanol

Injection into the cutaneous Neurofibromas lesion.

DEVICE

1064nm Nd:YAG laser

Pulse laser at a wavelength of 1064nm to the cutaneous Neurofibromas lesion.

DEVICE

755nm Alexandrite Laser

Pulse laser at a wavelength of 755nm to the cutaneous Neurofibromas lesion

Trial Locations (1)

02114

RECRUITING

Wellman Center for Photomedicine, Boston

All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

lead

Massachusetts General Hospital

OTHER